On behalf of the entire team at Biologics Consulting, we hope that you are well and staying healthy. As a global community, we face the challenge of responding and preparing appropriately for the novel coronavirus, SARS-CoV-2, responsible for the COVID-19 pandemic. While this is uncharted territory for all of us, we at Biologics Consulting are doing all we can to help ensure the safety and well-being of our employees, maintaining operational excellence and supporting our clients around the world. There has been no impact on our business operations as a result of the pandemic.
As a mature company with 27 years of experience providing regulatory consulting services to clients like you, we have long had a plan in place to continue our operations in case of unexpected natural interruptions. With Consultants across the U.S., virtual worksites are nothing new to us. Biologics Consulting has supported a remote office environment since our inception in 1993 and our plan ensures that we will be able to continue our support to you regardless of events, such as the spread of COVID-19.
We are actively supporting clients who are developing countermeasures for the COVID-19 pandemic – from vaccines and therapeutics to devices and diagnostics. If your company is working toward a COVID-19 intervention and you are seeking regulatory and/or product development support at any stage of the process, we stand ready to assist you. Consistent with our mission, we strive to support clients developing products to meet public health needs .
Our management team continuously reviews updated guidance from the World Health Organization, the Centers for Disease Control and Prevention (CDC), and other agencies, and we will adapt our response accordingly.
In the interim, we encourage you to reach out to us with any questions and/or comments regarding how we can best serve you during this time.